ENGLISH
繁體中文 ENGLISH

Investors-Financial Information

Material Information

Home

Investors

Financial Information

Material Information

Material Information Announcement

Click on the Market Observation Post System for public information, where you can search for significant information by year/month. Please enter the code 6782 for Visco Vision Inc. on the page linked.

SEQ_NO 1
Date of announcement 2023/05/30
Time of announcement 17:01:19
To which item it meets paragraph 21
Date of events 2023/05/30
Subject To announce the proposal of release the prohibition on directors from participation in competitive business.
Statement
  1. Date of the shareholders meeting resolution:2023/05/30
  2. Name and title of the director with permission to engage in competitive conduct:
    director:Chung-I Lee
    director:Ke-Yung Yu
    director:BenQ Materials Corp. representative:Pei-I Liu
    independent director:Chiu-Jui Wei
    independent director:Ying-Chou Yang
    independent director:Wei-Ting Lai
  3. Items of competitive conduct in which the director is permitted to engage:
    (1)Chung-I Lee
    Corporate Chairperson Representative, From-eyes Co., Ltd
    (2)Ke-Yung Yu
    Corporate Director Representative, From-eyes Co., Ltd
    (3)BenQ Materials Corp.
    Director, Cenefom Corp.
    Director, Lagis Enterprise Co., Ltd
    Director, Coatmed Incorporation
    Director, GENEJET BIOTECH CO., LTD
    President, WEB-PRO Corp.
    Production and manufacturing of contact lenses
    (4)BenQ Materials Corp. Representative:Pei-I Liu
    Vice President, BenQ Materials Corp.
    Corporate Director Representative, GENEJET BIOTECH CO., LTD
    Corporate Director Representative, Cenefom Corp.
    (5)Chiu-Jui Wei
    Senior Vice President, Compal Electronics
    President, Compal Ruifang Health Assets Development Corporation
    Corporate Director Representative, GENERAL LIFE BIOTECHNOLOGY CO., LTD
    Corporate Director Representative, Taiwan Star Telecom Corporation Limited
    Corporate Director Representative, UNICORE BIOMEDICAL CO., LTD
    Corporate Director Representative, Raycore Biotech Co., Ltd.
    Corporate Director Representative, CDIB & PARTNERS INVESTMENT HOLDING CORPORATION
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company
    Corporate Director Representative, Zhengying Electronic (Chongqing) Co., Ltd
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd
    Corporate Director Representative, Rayonnant Technology Co., Ltd
    Corporate Director Representative, Hua Vi Venture Capital Corporation
    Corporate Director Representative, Hua Qi Venture Capital Corporation
    Corporate Director Representative, IIH Biomedical Venture Fund I Co., Ltd
    Corporate Director Representative, Chenfeng Optronics Co., Ltd
    Corporate Director Representative, Arce Therapeutics Inc.
    Independent Director, SYNergy ScienTech Corp.
    (6)Ying-Chou Yang
    Independent Director, TSRC Corporation
    (7)Wei-Ting Lai
    Director of Ophthalmology, Min-Sheng General Hospital
    CMO, EyePlus
    Director, EyePlus
  4. Period of permission to engage in the competitive conduct:2023/05/30~2026/05/29
  5. Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):
    Under Article 209 of the Company Act, the resolution is approved by the Company's Annual General Shareholders' Meeting on 2023/05/30.
  6. If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors
    (if it is not the operator of a Mainland-area enterprise, please enter “N/A” below):
    independent director:Chiu-Jui Wei
  7. Company name of the mainland China area enterprise and the director's position in the enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company
    Corporate Director Representative, Zhengying Electronic (Chongqing) Co., Ltd
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd
  8. Address of the mainland China area enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company:No. 40, Yueyang Road, Taiwan-funded Science and Technology
    Innovation Industrial Park, Shaxi Town, Taicang City, Jiangsu Province
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company:No.18 Jubao Road, Jurong City, Zhenjiang City, Jiangsu Province
    Corporate Director Representative, Zhengying Electronic (Chongqing) Co., Ltd:No. 505, Tonghe Avenue, Tongliang District, Chongqing
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd:No. 326, Yixin Avenue, Youting Town, Dazu District, Chongqing
  9. Operations of the mainland China area enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company:Research and Developement、Production and Sales of new type Electronic Component
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company:Production of new alloy materials (magnesium/aluminum alloy) and related products (precision machining)
    Corporate Director Representative, Zhengying Electronic (Chongqing) Co., Ltd:Production and Sales of fine punching dies, precision cavity dies, die standard parts, new electronic components
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd:3C product organization manufacturing
  10. Impact on the company's finance and business:N/A
  11. If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A
  12. Any other matters that need to be specified:N/A
Go Back